FigureAsia
Nomination Awards Winner

Science

Thirty-five scientists under 35 whose work changed what can be proved, measured, built or understood—and whose 2025–26 record carries consequence well beyond a single laboratory.

Hong Wang Featured honouree Hong Wang Mathematics · China / France / United States

Purpose and scope

The Editorial Perspective

Scientific prestige is abundant; decisive contribution is rarer. This edition starts with the work itself: a theorem that closes a major open problem, an experiment that creates a new operating limit, a method other researchers can use, or a system that turns a difficult scientific task into a tractable one.

The cohort ranges from pure mathematics and quantum materials to vaccine science, climate systems and machine intelligence. What joins it is not fashion but evidence. Credit follows authorship, declared contribution, laboratory leadership and documented implementation; institutional reputation is context, never a substitute for agency.

Asia is treated as an intellectual network rather than a border. The list includes scientists working across the region and members of its diaspora whose education, identity or research programme maintains a substantive Asian connection.

Category definition

What FigureAsia means by science

Science covers work that produces testable knowledge about natural, mathematical or computational systems, together with research engineering that materially expands the ability to observe, simulate or intervene. The scope includes mathematics, physics, chemistry, materials, life science, climate and scientific computing.

Commercial success alone does not qualify. Applied work must retain a scientific core: a validated method, a reproducible experiment, a measurable technical advance or a research platform whose contribution can be separated from promotion.

Selection priorities

Discovery with a record behind it

Priority went to completed 2025–26 results, unusually important work still shaping a field, and clear individual responsibility. Citation counts, awards and competitive fellowships informed reach; none could rescue a weak contribution record.

The editors distinguished a paper's claim from its possible future effect. Benchmarks were kept inside their stated conditions, preclinical work was not described as treatment, and team science was credited without turning one author into the whole team.

FigureAsia methodology

How the field was assessed

Research began with primary papers, contribution statements, institutional records, award citations and public technical documentation. Independent reporting and field recognition were used where they clarified consequence, age or context.

Each eligible file was scored across eleven dimensions totalling 100 points. Scores express an editorial comparison of the documented record available by 18 July 2026; they are neither forecasts nor measures of personal worth.

Editorial judgement

Work before reputation

A celebrated institution did not earn a place on this list. The decisive question was whether an individual had helped deliver a result important enough to alter what a field can prove, measure or build.

The ranking weighs novelty, validation, reach, responsibility and scientific restraint. Team achievements remain team achievements; the profiles identify the part each honouree can fairly claim.

01 20%

Substantive 2025–2026 contribution

The scale and substance of completed work inside the edition period.

02 15%

Verified scientific impact

The degree to which the result has been validated, adopted, cited or recognised by the field.

03 10%

Originality and distinction

The novelty of the idea, proof, instrument, experiment or scientific capability.

04 10%

Field influence

The work's effect on research direction, professional practice or adjacent disciplines.

05 10%

Individual agency

Evidence that the honouree originated, led or carried accountable responsibility for the contribution.

06 5%

Durability and trajectory

Whether the result belongs to a coherent programme capable of outlasting a single announcement.

07 5%

Asian significance and global relevance

The materiality of the Asian connection and the work's relevance across borders.

08 8%

Evidential validity and reproducibility

The strength of methods, controls, declared assumptions, open artefacts and independent scrutiny.

09 7%

Advance in scientific knowledge

The extent to which the work changes what the field knows, can prove or can observe.

10 5%

Translational or methodological utility

The value of the result as a platform, tool, process or route toward practical use.

11 5%

Responsible research stewardship

Attention to limits, safety, data, access, attribution and the obligations attached to scientific power.

Eligibility

The line every honouree had to clear

Every honouree was assessed as 34 or younger on 31 December 2025. Ages are shown by the strongest available public year; exact birthdays are omitted where no authoritative record exists.

Each person also had to show a substantive Asian or Asian-diaspora connection and an active scientific record. Inclusion turned on documented contribution, not institutional prestige alone.

Contribution before affiliation

A prestigious institution or celebrated laboratory cannot substitute for identifiable individual work.

Completed evidence before promise

Projected applications are context. Scoring rests on a proof, publication, experiment, dataset, system or implementation already delivered.

Claims stay inside the evidence

Benchmarks retain their conditions; preclinical science is not presented as clinical benefit; correlation is not rewritten as causation.

Team science keeps its team

Profiles identify first, corresponding, senior or declared contribution without assigning a collaboration's full output to one person.

Age uncertainty is disclosed

Where only a birth year or recognised under-35 qualification is public, the edition uses an approximate year and does not invent a precise birthday.

The record

What this edition does—and does not—claim

Scientific consequence deserves clear attribution, a date and an honest account of uncertainty.

01

Evidence and attribution

Primary papers and institutional records support material claims. Authorship and contribution are described at the level the source permits.

02

Dates and changing roles

Roles, affiliations and results are stated against the evidence cutoff of 18 July 2026 and may change after publication.

03

Scientific uncertainty

Inclusion does not certify every future application. Results remain subject to replication, extension and correction through normal scientific practice.

04

Corrections

FigureAsia welcomes precise, documented corrections to identity, affiliation, authorship, age band or scientific claims.

05

Originality and copyright

The selection, ranking, framework and editorial prose are original FigureAsia work. Underlying scientific facts and third-party images remain subject to their own rights.

06

Originality and copyright

The selection, ranking, framework and editorial prose are original FigureAsia work. Underlying scientific facts and third-party images remain subject to their own rights.